(Q41351593)

29 September 2017

title

Treatment against human endogenous retrovirus: a possible personalized medicine approach for multiple sclerosis (English)

1 reference

29 September 2017

main subject

personalized medicine

1 reference

2

Hervé Perron

1 reference

29 September 2017

5

Alois B Lang

1 reference

29 September 2017

François Curtin

1

1 reference

29 September 2017

Raphael Faucard

series ordinal

3

1 reference

29 September 2017

Hervé Porchet

series ordinal

4

1 reference

29 September 2017

publication date

16 September 2015

1 reference

Molecular Diagnosis and Therapy

29 September 2017

published in

1 reference

29 September 2017

volume

19

1 reference

29 September 2017

issue

5

1 reference

29 September 2017

page(s)

255-265

1 reference

Multiple sclerosis: a complicated picture of autoimmunity.

29 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS40291-015-0166-Z

Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-015-0166-Z

The epidemiology of multiple sclerosis in Europe.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-015-0166-Z

The immunopathology of multiple sclerosis: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-015-0166-Z

Recent developments in multiple sclerosis therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-015-0166-Z

Novel therapeutic options for multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-015-0166-Z

Promoting remyelination in multiple sclerosis: current drugs and future prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-015-0166-Z

Phylogeny of a novel family of human endogenous retrovirus sequences, HERV-W, in humans and other primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-015-0166-Z

Long-term reinfection of the human genome by endogenous retroviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-015-0166-Z

The discovery of endogenous retroviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-015-0166-Z

The enemy within: endogenous retroelements and autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-015-0166-Z

Endogenous viruses: insights into viral evolution and impact on host biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-015-0166-Z

Human endogenous retrovirus protein activates innate immunity and promotes experimental allergic encephalomyelitis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-015-0166-Z

Multiple sclerosis-associated retroviral agent (MSRV)-stimulated cytokine production in patients with relapsing-remitting multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-015-0166-Z

Multiple sclerosis-associated retrovirus particles cause T lymphocyte-dependent death with brain hemorrhage in humanized SCID mice model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-015-0166-Z

Mechanisms for the induction of autoimmunity by infectious agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-015-0166-Z

Infections and autoimmunity: the multifaceted relationship

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-015-0166-Z

Human endogenous retrovirus type W envelope protein inhibits oligodendroglial precursor cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-015-0166-Z

The response of NG2-expressing oligodendrocyte progenitors to demyelination in MOG-EAE and MS

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-015-0166-Z

NG2-expressing cells as oligodendrocyte progenitors in the normal and demyelinated adult central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-015-0166-Z

Demyelination arrest and remyelination induced by glatiramer acetate treatment of experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-015-0166-Z

Remyelination therapy for multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-015-0166-Z

Human endogenous retrovirus glycoprotein-mediated induction of redox reactants causes oligodendrocyte death and demyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-015-0166-Z

Human endogenous retrovirus (HERV)-W ENV and GAG proteins: physiological expression in human brain and pathophysiological modulation in multiple sclerosis lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-015-0166-Z

Human endogenous retrovirus type W envelope expression in blood and brain cells provides new insights into multiple sclerosis disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-015-0166-Z

Preclinical and early clinical development of GNbAC1, a humanized IgG4 monoclonal antibody targeting endogenous retroviral MSRV-Env protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-015-0166-Z

The neutralizing antibody GNbAC1 abrogates HERV-W envelope protein-mediated oligodendroglial maturation blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-015-0166-Z

Tumor necrosis factor-α impairs oligodendroglial differentiation through a mitochondria-dependent process

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-015-0166-Z

GNbAC1, a humanized monoclonal antibody against the envelope protein of multiple sclerosis-associated endogenous retrovirus: a first-in-humans randomized clinical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-015-0166-Z

A phase IIa randomised clinical study of GNbAC1, a humanised monoclonal antibody against the envelope protein of multiple sclerosis-associated endogenous retrovirus in multiple sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-015-0166-Z

A phase IIa randomized clinical study testing GNbAC1, a humanized monoclonal antibody against the envelope protein of multiple sclerosis associated endogenous retrovirus in multiple sclerosis patients - a twelve month follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-015-0166-Z

Novel reliable real-time PCR for differential detection of MSRVenv and syncytin-1 in RNA and DNA from patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-015-0166-Z

The DNA copy number of human endogenous retrovirus-W (MSRV-type) is increased in multiple sclerosis patients and is influenced by gender and disease severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-015-0166-Z

Multiple sclerosis-associated retrovirus in early multiple sclerosis: a six-year follow-up of a Sardinian cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-015-0166-Z

Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-015-0166-Z

Inhibition of multiple-sclerosis-associated retrovirus as biomarker of interferon therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-015-0166-Z

Natalizumab inhibits the expression of human endogenous retroviruses of the W family in multiple sclerosis patients: a longitudinal cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-015-0166-Z

Multiple sclerosis: current and emerging disease-modifying therapies and treatment strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-015-0166-Z

The human endogenous retrovirus link between genes and environment in multiple sclerosis and in multifactorial diseases associating neuroinflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-015-0166-Z

Requirement for safety monitoring for approved multiple sclerosis therapies: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-015-0166-Z

Biomarkers of therapeutic response in multiple sclerosis: current status

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-015-0166-Z

Personalized medicine in neurodegenerative diseases: how far away?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-015-0166-Z

Molecular characteristics of Human Endogenous Retrovirus type-W in schizophrenia and bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-015-0166-Z

Molecular mimicry and immunomodulation by the HRES-1 endogenous retrovirus in SLE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-015-0166-Z

Rheumatoid arthritis is associated with IgG antibodies to human endogenous retrovirus gag matrix: a potential pathogenic mechanism of disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-015-0166-Z

Identification of active loci of a human endogenous retrovirus in neurons of patients with amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-015-0166-Z

Remyelination in multiple sclerosis

21 January 2018

1 reference

12 December 2020

Superantigen antagonist protects against lethal shock and defines a new domain for T-cell activation

1 reference

12 December 2020

Detection of virion-associated MSRV-RNA in serum of patients with multiple sclerosis

1 reference

12 December 2020

Infectious diseases and autoimmunity

1 reference

12 December 2020

Activation and clonal expansion of human myelin basic protein-reactive T cells by bacterial superantigens

1 reference

12 December 2020

Correlation between disease severity and in vitro cytokine production mediated by MSRV (Multiple Sclerosis associated RetroViral element) envelope protein in patients with multiple sclerosis

1 reference

12 December 2020

Multiple Sclerosis and HERV-W/MSRV: A Multicentric Study

1 reference

12 December 2020

Biology of oligodendrocyte and myelin in the mammalian central nervous system

1 reference

12 December 2020

The envelope protein of a human endogenous retrovirus-W family activates innate immunity through CD14/TLR4 and promotes Th1-like responses

1 reference

12 December 2020

Multiple sclerosis-associated retrovirus (MSRV) in Sardinian MS patients

1 reference

12 December 2020

Multiple sclerosis-associated retrovirus and MS prognosis: an observational study

1 reference

12 December 2020

Involvement of human intracisternal A-type retroviral particles in autoimmunity

1 reference

12 December 2020

Remyelination in multiple sclerosis

1 reference

12 December 2020

Multiple sclerosis-associated retrovirus and progressive disability of multiple sclerosis

1 reference

12 December 2020

Multiple sclerosis retrovirus particles and recombinant envelope trigger an abnormal immune response in vitro, by inducing polyclonal Vbeta16 T-lymphocyte activation

1 reference

12 December 2020

Human Endogenous Retroviruses (HERVs) and Autoimmune Rheumatic Disease: Is There a Link?

1 reference

12 December 2020

10.1007/S40291-015-0166-Z

Identifiers

DOI

1 reference

29 September 2017

1 reference